Guardant Health Ordered to Pay $245.2M for DNA Sequencing Patent Infringement

GH Guardant Health Inc

$155.35 -2.17%

View chart & analysis →

TVTX +0.70%

1. 1A U.S. court ordered Guardant Health (GH) to pay $245.2 million for infringing DNA sequencing patents held by TwinStrand and the University of Washington.
2. 2The award covers damages, accumulated royalties, and interest across 11 products, with quarterly royalty payments of 6% due until the patents expire in March 2033.
3. 3Guardant Health plans to appeal the ruling, and its shares fell 3.6% at the market open following the verdict.

Source Investor's Business Daily +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →